While VEGFA is known to be an important mediator of the abnormal blood vessel growth that characterizes late-stage neovascular AMD and is the target of current therapies for the treatment of disease33,47,48, our data demonstrate in humans a specific subpopulation of retinal astrocytes that are a source of this signal. This evidence concerns the gene VEGFA and age-related macular degeneration.